Showing results (1-10 of 128) with videos related to

Sort By:
Pageof 13
Expert Opinion on Drug Metabolism & Toxicology|February 18, 2011
Eritoran tetrasodium (E5564) treatment for sepsis: review of preclinical and clinical studiesAmisha Barochia, Steven Solomon, Xizhong Cui, et al.
Current Opinion in Critical Care|December 24, 2004
Defining the standard of care in randomized controlled trials of titrated therapiesKatherine J Deans, Peter C Minneci, Peter Q Eichacker, et al.
Biologics : Targets & Therapy|September 24, 2009
Growing insights into the potential benefits and risks of activated protein C administration in sepsis: a review of preclinical and clinical studiesLaith Altaweel, Daniel Sweeney, Xizhong Cui, et al.
Expert Opinion on Investigational Drugs|October 4, 2011
The evolving experience with therapeutic TNF inhibition in sepsis: considering the potential influence of risk of deathPing Qiu, Xizhong Cui, Amisha Barochia, et al.
Critical Care Medicine|July 27, 2013
Antitumor necrosis factor therapy is associated with improved survival in clinical sepsis trials: a meta-analysisPing Qiu, Xizhong Cui, Junfeng Sun, et al.
The Journal of Trauma|April 13, 2005
Novel therapies for sepsis: a reviewKatherine J Deans, Michael Haley, Charles Natanson, et al.
Annals of Internal Medicine|July 9, 2004
Meta-analysis: the effect of steroids on survival and shock during sepsis depends on the dosePeter C Minneci, Katherine J Deans, Steven M Banks, et al.
Annals of Internal Medicine|February 21, 2018
Evidence Underpinning the Centers for Medicare & Medicaid Services' Severe Sepsis and Septic Shock Management Bundle (SEP-1): A Systematic ReviewDominique J Pepper, Dharmvir Jaswal, Junfeng Sun, et al.
Critical Care Medicine|August 2, 2019
Antibiotic- and Fluid-Focused Bundles Potentially Improve Sepsis Management, but High-Quality Evidence Is Lacking for the Specificity Required in the Centers for Medicare and Medicaid Service's Sepsis Bundle (SEP-1)Dominique J Pepper, Junfeng Sun, Xizhong Cui, et al.
Anesthesia and Analgesia|October 13, 2009
Practice misalignments in randomized controlled trials: Identification, impact, and potential solutionsKatherine J Deans, Peter C Minneci, Robert L Danner, et al.
Pageof 13